Literature DB >> 25615882

Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.

Christian Schön1, Martin Biel2, Stylianos Michalakis3.   

Abstract

Adeno-associated virus (AAV) vectors are the most widely used vehicle systems for neuronal gene transfer. This popularity is based on the non-pathogenic nature of AAVs and their versatility making them a multifunctional vector system for basic research and clinical applications. AAVs are successfully applied in clinical and pre-clinical gene therapy studies for inherited retinal disorders. Their excellent transduction profile and efficiency also boosted the use of AAV vectors in basic research. The AAV vector system can be easily modified and adjusted at multiple levels to allow for optimized and specific gene expression in target cells. Here, we will provide an overview on the AAV vector system and its applications focusing on gene transfer into retinal cells. Furthermore, we will outline and discuss strategies for the optimization of AAV gene transfer by modifications to the AAV vector expression cassette, the AAV capsid or the routes of vector administration.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AAV capsid; AAV genome; Adeno-associated virus; Gene therapy; Intravitreal injection; Retina; Subretinal injection

Mesh:

Year:  2015        PMID: 25615882     DOI: 10.1016/j.ejpb.2015.01.009

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  25 in total

1.  Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma.

Authors:  Alejandra Bosco; Sarah R Anderson; Kevin T Breen; Cesar O Romero; Michael R Steele; Vince A Chiodo; Sanford L Boye; William W Hauswirth; Stephen Tomlinson; Monica L Vetter
Journal:  Mol Ther       Date:  2018-08-24       Impact factor: 11.454

2.  A canine model for neuronal ceroid lipofuscinosis highlights the promise of gene therapy for lysosomal storage diseases.

Authors:  Jonathan E Phillips; Richard H Gomer
Journal:  Ann Transl Med       Date:  2016-10

3.  Vitreal delivery of AAV vectored Cnga3 restores cone function in CNGA3-/-/Nrl-/- mice, an all-cone model of CNGA3 achromatopsia.

Authors:  Wei Du; Ye Tao; Wen-Tao Deng; Ping Zhu; Jie Li; Xufeng Dai; Yuxin Zhang; Wei Shi; Xuan Liu; Vince A Chiodo; Xi-Qin Ding; Chen Zhao; Stylianos Michalakis; Martin Biel; Zuoming Zhang; Jia Qu; William W Hauswirth; Ji-Jing Pang
Journal:  Hum Mol Genet       Date:  2015-04-08       Impact factor: 6.150

Review 4.  Viral vectors for neuronal cell type-specific visualization and manipulations.

Authors:  Yuanyuan Liu; Shane Hegarty; Carla Winter; Fan Wang; Zhigang He
Journal:  Curr Opin Neurobiol       Date:  2020-04-25       Impact factor: 6.627

Review 5.  Nanoparticle-motivated gene delivery for ophthalmic application.

Authors:  Rajendra Narayan Mitra; Min Zheng; Zongchao Han
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-06-22

6.  Synthetic Adeno-Associated Viral Vector Efficiently Targets Mouse and Nonhuman Primate Retina In Vivo.

Authors:  Livia S Carvalho; Ru Xiao; Sarah J Wassmer; Aliete Langsdorf; Eric Zinn; Simon Pacouret; Samiksha Shah; Jason I Comander; Leo A Kim; Laurence Lim; Luk H Vandenberghe
Journal:  Hum Gene Ther       Date:  2018-03-20       Impact factor: 5.695

7.  Cell-specific gene therapy driven by an optimized hypoxia-regulated vector reduces choroidal neovascularization.

Authors:  Manas R Biswal; Howard M Prentice; George W Smith; Ping Zhu; Yao Tong; C Kathleen Dorey; Alfred S Lewin; Janet C Blanks
Journal:  J Mol Med (Berl)       Date:  2018-08-13       Impact factor: 4.599

Review 8.  Principles of pharmacology in the eye.

Authors:  Sahar Awwad; Abeer H A Mohamed Ahmed; Garima Sharma; Jacob S Heng; Peng T Khaw; Steve Brocchini; Alastair Lockwood
Journal:  Br J Pharmacol       Date:  2017-10-10       Impact factor: 8.739

9.  Mouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells.

Authors:  Qizhao Wang; Pei Zhuang; Haoliang Huang; Liang Li; Liang Liu; Hannah C Webber; Roopa Dalal; Leonard Siew; Clarisse M Fligor; Kun-Che Chang; Michael Nahmou; Alexander Kreymerman; Yang Sun; Jason S Meyer; Jeffrey Louis Goldberg; Yang Hu
Journal:  J Neurosci       Date:  2020-04-16       Impact factor: 6.167

10.  Comparison of Different Liquid Chromatography-Based Purification Strategies for Adeno-Associated Virus Vectors.

Authors:  Ruth Rieser; Johanna Koch; Greta Faccioli; Klaus Richter; Tim Menzen; Martin Biel; Gerhard Winter; Stylianos Michalakis
Journal:  Pharmaceutics       Date:  2021-05-18       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.